Revenue from Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table summarizes revenue by source as follows:

	Three Months Ended March 31,
Major Products/Service Lines (in thousands)	2025		2024
Product revenue, net(1)	$	366,918	$	369,313
License and royalty revenues	5,846		662
Total revenues	$	372,764	$	369,975

________________________________

(1)The Company’s product revenue includes PYLARIFY and DEFINITY among other products. This category represents the delivery of physical goods. The Company applies the same revenue recognition policies and judgments for all its principal products.

Revenue by product category on a net basis is as follows:

	Three Months Ended March 31,
(in thousands)	2025		2024
PYLARIFY	$	257,654	$	258,870
Other radiopharmaceutical oncology	—		384
Total radiopharmaceutical oncology	257,654		259,254
DEFINITY	79,211		76,564
TechneLite	19,711		21,714
Other precision diagnostics	5,441		5,932
Total precision diagnostics	104,363		104,210
Strategic partnerships and other revenue	10,747		6,511
Total revenues	$	372,764	$	369,975